Selected antirhodopsin antibody consensus epitopes for mAbs with preference for metarhodopsin II, mapped to the cytoplasmic face of the dark rhodopsin X-ray structure. See Figure 4 ▶ legend for explanation of the color scheme and other relevant details.(A, B) Views of two different mappings of the mAb K16-111C consensus peptide, WAPEVMGPL. (A) WAPEVMGPL mapped on rhodopsin residues as VAPNVMGPL (mapping 1 for this mAb from Table 4). (B) WAPEVMGPL mapped on rhodopsin residues as AAAEVMGPL (mapping 3 for this mAb from Table 4). (C, D) Views of two different mappings of the mAb K16-155C consensus peptide, RSEAEMVAP. (C) RSEAEMVAP mapped on rhodopsin residues as KAEKEMVAP (mapping 1 for this mAb from the Supplemental Material). (D) RSEAEMVAP mapped on rhodopsin residues as RTEKEMVAP (mapping 3 for this mAb from the Supplemental Material).